Publication:
Impaired Respiratory Burst Contributes to Infections in PKC-Deficient Patients

dc.authorscopusid56798534900
dc.authorscopusid55258881600
dc.authorscopusid56184682500
dc.authorscopusid57201361923
dc.authorscopusid56946108200
dc.authorscopusid8309372700
dc.authorscopusid6602102891
dc.authorwosidMigaud, Mélanie/H-8044-2017
dc.authorwosidLachmann, Nico/H-6219-2017
dc.authorwosidBelot, Alexandre/C-7378-2013
dc.authorwosidDogu, Figen/Aai-1316-2020
dc.authorwosidLevy, Romain/Aam-6426-2020
dc.authorwosidParvaneh, Nima/A-2523-2010
dc.contributor.authorNeehus, Anna-Lena
dc.contributor.authorMoriya, Kunihiko
dc.contributor.authorNieto-Patlan, Alejandro
dc.contributor.authorLe Voyer, Tom
dc.contributor.authorLevy, Romain
dc.contributor.authorOzen, Ahmet
dc.contributor.authorBustamante, Jacinta
dc.contributor.authorIDBaris, Safa/0000-0002-4730-9422
dc.contributor.authorIDHaake, Kathrin/0000-0002-3713-2694
dc.contributor.authorIDKarakoc-Aydiner, Elif/0000-0003-4150-5200
dc.contributor.authorIDNeehus, Anna-Lena/0000-0002-8573-6820
dc.contributor.authorIDGorochov, Guy/0000-0003-2097-9677
dc.contributor.authorIDMoriya, Kunihiko/0000-0002-0418-5132
dc.date.accessioned2025-12-11T01:38:34Z
dc.date.issued2021
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Neehus, Anna-Lena; Moriya, Kunihiko; Nieto-Patlan, Alejandro; Le Voyer, Tom; Levy, Romain; Roynard, Manon; Migaud, Melanie; Abel, Laurent; Casanova, Jean-Laurent; Puel, Anne; Bustamante, Jacinta] Inst Natl Sante & Rech Med UMR 1163, Necker Branch, Lab Human Genet Infect Dis, Paris, France; [Neehus, Anna-Lena; Moriya, Kunihiko; Nieto-Patlan, Alejandro; Le Voyer, Tom; Levy, Romain; Roynard, Manon; Migaud, Melanie; Abel, Laurent; Casanova, Jean-Laurent; Puel, Anne; Bustamante, Jacinta] Univ Paris, Imagine Inst, Paris, France; [Neehus, Anna-Lena; Haake, Kathrin; Lachmann, Nico] Hannover Med Sch, REBIRTH Res Ctr Translat & Regenerat Med, Inst Expt Hematol, Hannover, Germany; [Nieto-Patlan, Alejandro] Natl Polytech Inst, Natl Sch Biol Sci, Res & Dev Bioproc Unit, Mexico City, DF, Mexico; [Nieto-Patlan, Alejandro] LANSEIDI FarBiotec CONACyT, Natl Lab Specialized Serv Invest Dev & Innovat Ph, Mexico City, DF, Mexico; [Levy, Romain] Necker Hosp Sick Children, Pediat Hematol Immunol Unit, Paris, France; [Ozen, Ahmet; Karakoc-Aydiner, Elif; Baris, Safa] Marmara Univ, Sch Med, Dept Pediat, Div Allergy & Immunol, Istanbul, Turkey; [Yildiran, Alisan; Hancioglu, Gonca] Ondokuz Mayis Univ, Dept Pediat Immunol & Allergy, Sch Med, Samsun, Turkey; [Altundag, Engin] Ondokuz Mayis Univ, Dept Med Genet, Fac Med, Samsun, Turkey; [Dorgham, Karim; Gorochov, Guy] Sorbonne Univ, Inst Natl Sante & Rech Med, Ctr Immunol & Microbial Infect,CIMI Paris, Pitie Salpetriere Hosp,Assistance Publ Hop Paris, Paris, France; [Abel, Laurent; Casanova, Jean-Laurent; Puel, Anne; Bustamante, Jacinta] Rockefeller Univ, Rockefeller Branch, St Giles Lab Human Genet Infect Dis, 1230 York Ave, New York, NY 10021 USA; [Dogu, Figen; Haskologlu, Sule; Ikinciogullari, Aydan] Ankara Univ, Dept Pediat Immunol & Allergy, Sch Med, Ankara, Turkey; [Ince, Erdal] Ankara Univ, Dept Pediat Infect Dis, Sch Med, Ankara, Turkey; [El-Benna, Jamel] Univ Paris, Ctr Natl Rech Sci ERL8252, Inst Natl Sante & Rech Med U1149, Paris, France; [El-Benna, Jamel] Ctr Res Inflammat, Fac Med, Lab Excellence Inflamex, Paris, France; [Uzel, Gulbu] NIAID, Lab Clin Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Kiykim, Ayca] Marmara Univ, Pediat Allergy & Immunol, Pediat Training & Res Hosp, Istanbul, Turkey; [Kiykim, Ayca] Istanbul Univ Cerrahpasa, Cerrahpasa Sch Med, Div Pediat Allergy & Immunol, Istanbul, Turkey; [Boztug, Kaan] Austrian Acad Sci, CeMM Res Ctr Mol Med, Vienna, Austria; [Boztug, Kaan] Med Univ Vienna, Dept Pediat & Adolescent Med, St Anna Childrens Hosp, Vienna, Austria; [Boztug, Kaan] Ludwig Boltzmann Inst Rare & Undiagnosed Dis, Vienna, Austria; [Boztug, Kaan] St Anna Childrens Canc Res Inst, Vienna, Austria; [Roderick, Marion R.] Bristol Royal Hosp Children, Pediat Immunol & Infect Dis, Bristol, Avon, England; [Shahrooei, Mohammad] Sina Med Complex, Specialized Immunol Lab Dr Shahrooei, Ahvaz, Iran; [Shahrooei, Mohammad] Katholieke Univ Leuven, Dept Microbiol & Immunol, Clin & Diagnost Immunol, Leuven, Belgium; [Brogan, Paul A.] UCL, Rheumatol Sect, Inst Child Hlth, Inflammat & Physiol Med Programme, London, England; [Abolhassani, Hassan] Karolinska Univ Hosp Huddinge, Dept Lab Med, Div Clin Immunol, Karolinska Inst, Stockholm, Sweden; [Abolhassani, Hassan; Parvaneh, Nima] Univ Tehran Med Sci, Res Ctr Immunodeficiencies, Tehran, Iran; [Parvaneh, Nima] Univ Tehran Med Sci, Dept Pediat, Div Allergy & Clin Immunol, Tehran, Iran; [Belot, Alexandre] Lyon Univ, Reference Ctr Rare Rheumat & Autoimmune Dis Child, Hosp Civils Lyon,UMS3444 US8, Ctr Int Rech Infectiol,Inst Natl Sante & Rech Med, Lyon, France; [Casanova, Jean-Laurent] Howard Hughes Med Inst, New York, NY USA; [Bustamante, Jacinta] Necker Hosp Sick Children, Assistance Publ Hop Paris, Ctr Study Primary Immunodeficiencies, Paris, France; [Lachmann, Nico] Hannover Med Sch, RESIST Cluster Excellence, Dept Pediat Pneumol Allergol & Neonatol, Hannover, Germanyen_US
dc.descriptionBaris, Safa/0000-0002-4730-9422; Haake, Kathrin/0000-0002-3713-2694; Karakoc-Aydiner, Elif/0000-0003-4150-5200; Neehus, Anna-Lena/0000-0002-8573-6820; Gorochov, Guy/0000-0003-2097-9677; Moriya, Kunihiko/0000-0002-0418-5132; Puel, Anne/0000-0003-2603-0323; Altundağ, Engin/0000-0001-8841-1426; Abolhassani, Hassan/0000-0002-4838-0407; Kiykim, Ayca/0000-0001-5821-3963; Lévy, Romain/0000-0002-6393-0198; Brogan, Paul/0000-0001-6178-6893; Belot, Alexane/0000-0003-4902-5332; Roderick, Marion/0000-0002-8481-6300; Le Voyer, Tom/0000-0002-7253-3135; Casanova, Jean-Laurent/0000-0002-7782-4169; Yildiran, Alisan/0000-0002-2918-6238;en_US
dc.description.abstractPatients with autosomal recessive protein kinase C delta (PKC delta) deficiency suffer from childhood-onset autoimmunity, including systemic lupus erythematosus. They also suffer from recurrent infections that overlap with those seen in patients with chronic granulomatous disease (CGD), a disease caused by defects of the phagocyte NADPH oxidase and a lack of reactive oxygen species (ROS) production. We studied an international cohort of 17 PKC delta-deficient patients and found that their EBV-B cells and monocyte-derived phagocytes produced only small amounts of ROS and did not phosphorylate p40(phox) normally after PMA or opsonized Staphylococcus aureus stimulation. Moreover, the patients' circulating phagocytes displayed abnormally low levels of ROS production and markedly reduced neutrophil extracellular trap formation, altogether suggesting a role for PKC delta in activation of the NADPH oxidase complex. Our findings thus show that patients with PKC delta deficiency have impaired NADPH oxidase activity in various myeloid subsets, which may contribute to their CGD-like infectious phenotype.en_US
dc.description.sponsorshipYale Center for Mendelian Genomics - National Human Genome Research Institute [UM1HG006504]; National Institute of Allergy and Infectious Diseases [5R01AI089970, 5R37AI095983, R01AI127564-01]; National Center for Research Resources; National Center for Advancing Translational Sciences of the National Institutes of Health [8UL1TR001866]; Rockefeller University; St. Giles Foundation; INSERM; University of Paris; French Foundation for Medical Research [EQU201903007798]; Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence [ANR-10-LABX-62-IBEID]; SCOR Corporate Foundation for Science; French National Research Agency (ANR) under the "Investments for the future" program [ANR-10-IAHU-01]; ANR-IFNPHOX [ANR-13-ISV3-0001-01]; ANR-GENMSMD [ANR-16-CE17-0005-01]; ANR-GENCMCD [ANR-11-BSV3-005-01]; ANR-HGDIFD [ANR-14-CE15-0006-01]; Bettencourt Schueller Foundation; International PhD program of the Imagine Institute; Japanese Foundation; EURO-CMC project [ANR-14-RARE-0005-02]; Societe Nationale Francaise de Medecine Interne (Bourse Marcel Simon); INSERM PhD program for medical doctors (poste d'accueil INSERM); Fulbright grant (Franco-American commission); MD-PhD program of Imagine Institute; Consejo Nacional de Ciencia y Tecnologa National PhD Fellowship Program; National Institute for Health Research Biomedical Research Centre; Great Ormond Street Hospital Charity; Deutsche Forschungsgemeinschaft under Germany's Excellence Strategy [EXC 2155, 390874280]; REBIRTH Center for Translational Regenerative Medicine through the State of Lower Saxony [MWK: ZN3440]; Agence Nationale de la Recherche (ANR) [ANR-14-CE15-0006] Funding Source: Agence Nationale de la Recherche (ANR); Grants-in-Aid for Scientific Research [21K07791] Funding Source: KAKENen_US
dc.description.sponsorshipThis paper is dedicated to the memory of Prof. Asghar Agha-mohammadi, who passed away in November 2020, and made immense contributions to the understanding and treatment of primary immunodeficiencies. We thank all patients, their relatives, and the treatment teams for their cooperation in this study. We thank all the members of the Laboratory of Human Genetics of Infectious Diseases for helpful discussions. We also thank Christine Rivalain, Cecile Pa-tissier, Lazaro Lorenzo-Diaz, Dominick Papandrea, Dana Liu, and Yelena Nemirovskaya for administrative assistance and Gaspard Kerner for statistical advice. We thank the Necker Institute Imaging Facility for technical advice. The graphical abstract was created with BioRender.com under subscription. This research was supported by the Yale Center for Mendelian Genomics funded by the National Human Genome Research Insti-tute (UM1HG006504) . The Howard Hughes Medical Institute lab-oratory was funded in part by the National Institute of Allergy and Infectious Diseases (grants 5R01AI089970, 5R37AI095983, and R01AI127564-01) , the National Center for Research Resources, and the National Center for Advancing Translational Sciences of the National Institutes of Health (grant 8UL1TR001866 for J-L. Casa-nova) , the Rockefeller University, the St. Giles Foundation, INSERM, the University of Paris, the French Foundation for MedicalResearch (EQU201903007798) , the Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence (ANR-10-LABX-62-IBEID) , the SCOR Corporate Foundation for Science, and the French National Research Agency (ANR) under the "Investments for the future" program (grant ANR-10-IAHU-01) , ANR-IFNPHOX (grant ANR-13-ISV3-0001-01 for J. Bustamante) , ANR-GENMSMD (grant ANR-16-CE17-0005-01 for J. Bustamante) , ANR-GENCMCD (grant ANR-11-BSV3-005-01 for A. Puel) , and ANR-HGDIFD (grant ANR-14-CE15-0006-01 for J. Bustamante) . A-L. Neehus was sup-ported by the Bettencourt Schueller Foundation and the Interna-tional PhD program of the Imagine Institute, K. Moriya by a Japanese Foundation for Pediatric Research fellowship grant and EURO-CMC project (grant ANR-14-RARE-0005-02 for J. Bustamante) , R. Levy by the Societe Nationale Francaise de Medecine Interne (Bourse Marcel Simon) , the INSERM PhD program for medical doctors (poste d'accueil INSERM) , and the Fulbright grant (Franco-American commission) , T. Le Voyer by the Bettencourt Schueller Foundation and the MD-PhD program of Imagine Institute, and A. Nieto-Patlan by the Consejo Nacional de Ciencia y Tecnologa Na-tional PhD Fellowship Program. All research at the Great Ormond Street Hospital National Health Service Foundation Trust is sup-ported by the National Institute for Health Research Biomedical Research Centre. P.A. Brogan also acknowledges support from the Great Ormond Street Hospital Charity. N. Lachmann acknowledges support from the Deutsche Forschungsgemeinschaft under Ger-many's Excellence Strategy-EXC 2155-project number 390874280 and the REBIRTH Center for Translational Regenerative Medicine funded through the State of Lower Saxony (MWK: ZN3440) . Author contributions: A-L. Neehus, J-L. Casanova, A. Puel, and J. Bustamante conceived and designed the study. A-L. Neehus, K. Moriya, T. Le Voyer, A. Nieto-Patlan, R. Levy, M. Roynard, K. Haake, M. Migaud, and K. Dorgham performed the experiments. A. ozen, E. Karakoc-Aydiner, S. Baris, A. Yildiran, E. Altundag, F. Dogu, S. Has-kologlu, E. Ince, G. Uzel, A. Kiykim, K. Boztug, M.R. Roderick, M. Shahrooei, P.A. Brogan, H. Abolhassani, G. Hancioglu, N. Parvaneh, A. Belot, and A. Ikinciogullari were the treating physicians respon-sible for clinical diagnosis, deep phenotyping, sample collection, and patient follow-up. G. Gorochov, L. Abel, N. Lachmann, J. El-Benna, and A. Belot provided conceptual advice. A-L. Neehus, J-L. Casanova, A. Puel, and J. Bustamante analyzed the results and wrote the man-uscript. All authors revised the manuscript and approved the final manuscript as submitted. Disclosures: P.A. Brogan reported personal fees from Sobi, No-vartis, Roche, and GSK, and grants from Sobi outside the sub-mitted work. No other disclosures were reported.en_US
dc.description.woscitationindexScience Citation Index Expanded
dc.identifier.doi10.1084/jem.20210501
dc.identifier.issn0022-1007
dc.identifier.issn1540-9538
dc.identifier.issue9en_US
dc.identifier.scopus2-s2.0-85110699815
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://doi.org/10.1084/jem.20210501
dc.identifier.urihttps://hdl.handle.net/20.500.12712/45103
dc.identifier.volume218en_US
dc.identifier.wosWOS:000704364600012
dc.identifier.wosqualityQ1
dc.language.isoenen_US
dc.publisherRockefeller University Pressen_US
dc.relation.ispartofJournal of Experimental Medicineen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titleImpaired Respiratory Burst Contributes to Infections in PKC-Deficient Patientsen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files